An Innovative, Non-Hormonal, Pharmacological Strategy that Down-Regulates the Oestrogen, Androgen, Progesterone, and Prolactin Receptors and Inhibits the Triad-of-Death in Breast Cancer (Griffith led) (2023–2026)
- Grant type:
- Griffith University
- Researchers:
-
-
- Funded by:
- Griffith University
